PortfoliosLab logoPortfoliosLab logo
ARKG vs. MTUM
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

ARKG vs. MTUM - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in ARK Genomic Revolution Multi-Sector ETF (ARKG) and iShares MSCI USA Momentum Factor ETF (MTUM). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, ARKG achieves a 15.53% return, which is significantly lower than MTUM's 29.72% return. Over the past 10 years, ARKG has underperformed MTUM with an annualized return of 7.82%, while MTUM has yielded a comparatively higher 17.15% annualized return.


ARKG

1D
-0.53%
1M
18.90%
YTD
15.53%
6M
10.83%
1Y
42.61%
3Y*
-1.68%
5Y*
-17.27%
10Y*
7.82%

MTUM

1D
1.69%
1M
8.76%
YTD
29.72%
6M
30.51%
1Y
42.02%
3Y*
33.16%
5Y*
14.96%
10Y*
17.15%
*Multi-year figures are annualized to reflect compound growth (CAGR)

ARKG vs. MTUM - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
ARKG
ARK Genomic Revolution Multi-Sector ETF
15.53%23.04%-28.24%16.22%-53.90%-33.92%180.40%44.00%-1.26%46.61%
MTUM
iShares MSCI USA Momentum Factor ETF
29.72%22.15%32.89%9.15%-18.27%13.36%29.86%27.25%-1.67%37.50%

Correlation

The correlation between ARKG and MTUM is 0.43, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.43

Correlation (3Y)
Calculated over the trailing 3-year period

0.49

Correlation (5Y)
Calculated over the trailing 5-year period

0.53

Correlation (10Y)
Calculated over the trailing 10-year period

0.56

Correlation (All Time)
Calculated using the full available price history since Oct 31, 2014

0.56

The correlation between ARKG and MTUM shifts across timeframes, from 0.43 (1 year) to 0.56 (10 years), reflecting how their relationship changes across market environments.

ARKG vs. MTUM - Sectors Allocation Comparison


Sectors
ARKG
MTUM

Healthcare

99.3%
3.5%

Financial Services

0.5%
5.0%

Basic Materials

-

2.3%

Communication Services

-

5.1%

Consumer Cyclical

-

2.9%

Consumer Defensive

-

3.7%

Energy

-

10.5%

Industrials

-

15.0%

Real Estate

-

1.3%

Technology

-

50.2%

Utilities

-

0.6%

Healthcare

ARKG
99.3%
MTUM
3.5%

Financial Services

ARKG
0.5%
MTUM
5.0%

Basic Materials

ARKG

-

MTUM
2.3%

Communication Services

ARKG

-

MTUM
5.1%

Consumer Cyclical

ARKG

-

MTUM
2.9%

Consumer Defensive

ARKG

-

MTUM
3.7%

Energy

ARKG

-

MTUM
10.5%

Industrials

ARKG

-

MTUM
15.0%

Real Estate

ARKG

-

MTUM
1.3%

Technology

ARKG

-

MTUM
50.2%

Utilities

ARKG

-

MTUM
0.6%

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

ARKG vs. MTUM — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ARKG
ARKG Risk / Return Rank: 3232
Overall Rank
ARKG Sharpe Ratio Rank: 3131
Sharpe Ratio Rank
ARKG Sortino Ratio Rank: 3434
Sortino Ratio Rank
ARKG Omega Ratio Rank: 3030
Omega Ratio Rank
ARKG Calmar Ratio Rank: 3535
Calmar Ratio Rank
ARKG Martin Ratio Rank: 2929
Martin Ratio Rank

MTUM
MTUM Risk / Return Rank: 7373
Overall Rank
MTUM Sharpe Ratio Rank: 7070
Sharpe Ratio Rank
MTUM Sortino Ratio Rank: 6666
Sortino Ratio Rank
MTUM Omega Ratio Rank: 7070
Omega Ratio Rank
MTUM Calmar Ratio Rank: 7878
Calmar Ratio Rank
MTUM Martin Ratio Rank: 8181
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ARKG vs. MTUM - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for ARK Genomic Revolution Multi-Sector ETF (ARKG) and iShares MSCI USA Momentum Factor ETF (MTUM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


ARKGMTUMDifference
Sharpe ratioReturn per unit of total volatility

-0.97

Sortino ratioReturn per unit of downside risk

-1.00

Omega ratioGain probability vs. loss probability

1.18

1.36

-0.17

Calmar ratioReturn relative to maximum drawdown

1.52

3.55

-2.03

Martin ratioReturn relative to average drawdown

3.61

13.66

-10.04

ARKG vs. MTUM - Sharpe Ratio Comparison

The current ARKG Sharpe Ratio is 0.99, which is lower than the MTUM Sharpe Ratio of 1.96. The chart below compares the historical Sharpe Ratios of ARKG and MTUM, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

ARKG vs. MTUM - Drawdown Comparison

The maximum ARKG drawdown since its inception was -83.59%, which is greater than MTUM's maximum drawdown of -34.08%. Use the drawdown chart below to compare losses from any high point for ARKG and MTUM.


Loading charts...

Drawdown Indicators


ARKGMTUMDifference

Max Drawdown

Largest peak-to-trough decline

-83.59%

-34.08%

-49.51%

Max Drawdown (1Y)

Largest decline over 1 year

-27.51%

-11.54%

-15.97%

Max Drawdown (3Y)

Largest decline over 3 years

-51.96%

-20.99%

-30.97%

Max Drawdown (5Y)

Largest decline over 5 years

-80.18%

-32.28%

-47.90%

Max Drawdown (10Y)

Largest decline over 10 years

-83.59%

-34.08%

-49.51%

Current Drawdown

Current decline from peak

-70.05%

-1.55%

-68.50%

Average Drawdown

Average peak-to-trough decline

-35.95%

-6.20%

-29.75%

Ulcer Index

Depth and duration of drawdowns from previous peaks

11.53%

2.99%

+8.54%

Volatility

ARKG vs. MTUM - Volatility Comparison

ARK Genomic Revolution Multi-Sector ETF (ARKG) has a higher volatility of 15.35% compared to iShares MSCI USA Momentum Factor ETF (MTUM) at 10.89%. This indicates that ARKG's price experiences larger fluctuations and is considered to be riskier than MTUM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


ARKGMTUMDifference

Volatility (1M)

Calculated over the trailing 1-month period

15.35%

10.89%

+4.46%

Volatility (6M)

Calculated over the trailing 6-month period

30.29%

18.63%

+11.66%

Volatility (1Y)

Calculated over the trailing 1-year period

42.16%

20.87%

+21.29%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

45.81%

20.94%

+24.87%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

41.24%

21.20%

+20.04%

ARKG vs. MTUM - Expense Ratio Comparison

ARKG has a 0.75% expense ratio, which is higher than MTUM's 0.15% expense ratio.


Dividends

ARKG vs. MTUM - Dividend Comparison

ARKG has not paid dividends to shareholders, while MTUM's dividend yield for the trailing twelve months is around 0.61%.


PositionTTM20252024202320222021202020192018201720162015
ARKG
ARK Genomic Revolution Multi-Sector ETF
0.00%0.00%0.00%0.00%0.00%0.62%0.85%3.14%0.82%1.34%0.00%0.00%
MTUM
iShares MSCI USA Momentum Factor ETF
0.61%0.91%0.75%1.35%1.80%0.55%0.83%1.48%1.27%1.02%1.43%1.12%

Frequently Asked Questions


ARKG and MTUM have a correlation of 0.43, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

ARKG has higher volatility (15.35%) compared to MTUM (10.89%). In terms of maximum drawdown, ARKG dropped -83.59% vs MTUM's -34.08%.

On 10-year performance, MTUM leads with 17.15% vs 7.82% for ARKG. On fees, MTUM is cheaper at 0.15% per year. On volatility, MTUM has been the lower-risk option at 10.89%. The better choice depends on whether you care most about return, fees, risk, or income.

Over the 10-year period, MTUM has performed better with a 17.15% return vs 7.82%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

MTUM is cheaper with a 0.15% expense ratio, compared with 0.75% for ARKG.

MTUM has the higher dividend yield at 0.61%, compared with 0.00% for ARKG.

ARKG is categorized as Health & Biotech Equities, while MTUM is Momentum. They also come from different issuers: ARK and iShares. Their fees differ too: 0.75% for ARKG and 0.15% for MTUM.

MTUM currently has the higher Sharpe Ratio (1.96 vs 0.99), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for ARKG and MTUM

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer